17133-Urothelial Cancer-NA-458

Urothelial Cancer

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Address

4708 Alliance Blvd, Suite 150
Plano, TX 75093
P: (972) 596-7801

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.